LATEST NEWS

Researchers at LJI and Columbia University uncover exactly how a neutralizing antibody blocks measles virus infection
With new funding, LJI scientists will help lay the groundwork for faster vaccine and therapeutic development
LJI scientists share their visions for more effective, longer-lasting vaccines
LJI Research Assistant Professor Alba Grifoni, Ph.D., shares how her T cell research could propel vaccine development
New measles, Nipah research offers a window into viral assembly